Dr. Michael Soler, MD

NPI: 1285901140
Total Payments
$8,318
2024 Payments
$564.84
Companies
39
Transactions
590
Medicare Patients
2,118
Medicare Billing
$184,573

Payment Breakdown by Category

Food & Beverage$8,238 (99.0%)
Education$80.83 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,238 581 99.0%
Education $80.83 9 1.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,262 75 $0 (2024)
Novo Nordisk Inc $963.17 74 $0 (2024)
Lilly USA, LLC $781.25 76 $0 (2024)
SANOFI-AVENTIS U.S. LLC $563.49 37 $0 (2020)
Boehringer Ingelheim Pharmaceuticals, Inc. $533.11 36 $0 (2020)
Janssen Pharmaceuticals, Inc $532.68 34 $0 (2024)
PFIZER INC. $508.87 43 $0 (2024)
Amgen Inc. $357.76 27 $0 (2024)
Allergan, Inc. $298.55 19 $0 (2020)
Novartis Pharmaceuticals Corporation $280.22 18 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $564.84 30 Novo Nordisk Inc ($101.47)
2023 $32.87 2 Bayer Healthcare Pharmaceuticals Inc. ($19.62)
2020 $1,884 122 AstraZeneca Pharmaceuticals LP ($223.12)
2019 $1,888 154 AstraZeneca Pharmaceuticals LP ($242.31)
2018 $1,724 123 AstraZeneca Pharmaceuticals LP ($336.96)
2017 $2,225 159 AstraZeneca Pharmaceuticals LP ($410.53)

All Payment Transactions

590 individual payment records from CMS Open Payments — Page 1 of 24

Date Company Product Nature Form Amount Type
12/30/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $19.92 General
Category: RESPIRATORY
12/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.22 General
Category: Diabetes
12/13/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.59 General
Category: Inflammation
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $14.83 General
Category: Gastroenterology
11/21/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.65 General
Category: PAIN
11/18/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.20 General
Category: Diabetes
11/11/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.46 General
Category: Respiratory
11/05/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.96 General
Category: Diabetes
11/01/2024 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $19.03 General
Category: Diabetes
10/21/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.28 General
Category: Cardio-renal
10/07/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $32.26 General
Category: Cardiology/Vascular Diseases
10/03/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $23.96 General
Category: GASTROENTEROLOGY
10/02/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $16.52 General
Category: RESPIRATORY
09/30/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $14.92 General
Category: Oncology
09/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $14.30 General
Category: Gastroenterology
09/16/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.12 General
Category: PAIN
09/13/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $23.51 General
Category: Diabetes
09/07/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.65 General
Category: PSYCHIATRY
08/23/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $25.78 General
Category: RESPIRATORY
08/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.81 General
Category: Diabetes
08/06/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.79 General
Category: Diabetes
07/29/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.83 General
Category: Inflammation
07/15/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $23.74 General
Category: Diabetes Care
07/12/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.21 General
Category: Diabetes
07/09/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.19 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 497 1,588 $84,494 $46,268
2022 14 599 1,457 $87,376 $50,307
2021 13 564 1,066 $83,037 $50,052
2020 13 458 766 $69,513 $37,946
Total Patients
2,118
Total Services
4,877
Medicare Billing
$184,573
Procedure Codes
50

All Medicare Procedures & Services

50 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 181 555 $74,925 $40,366 53.9%
90732 Pneumococcal vaccine, 23-valent Office 2023 12 12 $1,740 $1,570 90.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 137 262 $1,310 $1,271 97.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 18 76 $2,280 $646.80 28.4%
G0008 Administration of influenza virus vaccine Office 2023 18 18 $540.00 $529.20 98.0%
G0009 Administration of pneumococcal vaccine Office 2023 17 17 $510.00 $499.80 98.0%
83036 Hemoglobin a1c level Office 2023 35 52 $780.00 $495.04 63.5%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 44 558 $1,674 $435.10 26.0%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2023 20 20 $600.00 $416.10 69.4%
81003 Automated urinalysis test Office 2023 15 18 $135.00 $39.60 29.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 189 524 $70,740 $40,632 57.4%
90732 Pneumococcal vaccine, 23-valent Office 2022 16 16 $2,320 $2,101 90.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 12 12 $1,800 $1,424 79.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 25 25 $3,250 $1,210 37.2%
G0008 Administration of influenza virus vaccine Office 2022 29 29 $870.00 $823.02 94.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 130 257 $1,285 $761.34 59.2%
G0009 Administration of pneumococcal vaccine Office 2022 24 24 $720.00 $684.89 95.1%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2022 30 30 $750.00 $632.70 84.4%
83036 Hemoglobin a1c level Office 2022 42 65 $975.00 $613.47 62.9%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 14 14 $1,330 $532.54 40.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 18 50 $1,500 $298.66 19.9%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 26 362 $1,086 $273.46 25.2%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 16 17 $510.00 $249.57 48.9%
81003 Automated urinalysis test Office 2022 28 32 $240.00 $70.94 29.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 190 492 $66,160 $40,043 60.5%

About Dr. Michael Soler, MD

Dr. Michael Soler, MD is a Family Medicine healthcare provider based in Portland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1285901140.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Soler, MD has received a total of $8,318 in payments from pharmaceutical and medical device companies, with $564.84 received in 2024. These payments were reported across 590 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,238).

As a Medicare-enrolled provider, Soler has provided services to 2,118 Medicare beneficiaries, totaling 4,877 services with total Medicare billing of $184,573. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Geriatric Medicine
  • Location Portland, TX
  • Active Since 11/21/2011
  • Last Updated 10/17/2014
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1285901140

Products in Payments

  • FARXIGA (Drug) $1,116
  • TRULICITY (Drug) $444.96
  • XARELTO (Drug) $392.92
  • Ozempic (Drug) $307.04
  • ENTRESTO (Drug) $280.22
  • TRADJENTA (Drug) $279.65
  • TOUJEO (Drug) $269.77
  • CHANTIX (Drug) $256.84
  • Victoza (Drug) $233.28
  • JARDIANCE (Drug) $225.59
  • JANUVIA (Drug) $212.88
  • Saxenda (Drug) $190.40
  • Aimovig (Biological) $189.50
  • TRELEGY ELLIPTA (Drug) $179.80
  • INVOKANA (Drug) $139.76
  • XIFAXAN (Drug) $138.16
  • UBRELVY (Drug) $137.26
  • NUEDEXTA (Drug) $131.82
  • SOLIQUA (Drug) $127.73
  • Yupelri (Drug) $122.71

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Portland